Biomarkers for liver fibrosis
Abstract
Methods and systems for diagnosing or prognosing liver fibrosis in a subject are provided. In some examples, such methods and systems can include detecting liver fibrosis-related molecules in a sample obtained from the subject, comparing expression of the molecules in the sample to controls representing expression values expected in a subject who does not have liver fibrosis or who has non-progressing fibrosis, and diagnosing or prognosing liver fibrosis in the subject when differential expression of the molecules between the sample and the controls is detected. Kits for the diagnosis or prognosis of liver fibrosis in a subject are also provided which include reagents for detecting liver fibrosis related molecules.
- Inventors:
- Issue Date:
- Research Org.:
- Pacific Northwest National Laboratory (PNNL), Richland, WA (United States)
- Sponsoring Org.:
- USDOE
- OSTI Identifier:
- 1214595
- Patent Number(s):
- 9134326
- Application Number:
- 14/209,860
- Assignee:
- Battelle Memorial Institute (Richland, WA)
- Patent Classifications (CPCs):
-
A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
G - PHYSICS G01 - MEASURING G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- DOE Contract Number:
- AC05-76RL01830
- Resource Type:
- Patent
- Resource Relation:
- Patent File Date: 2014 Mar 13
- Country of Publication:
- United States
- Language:
- English
- Subject:
- 59 BASIC BIOLOGICAL SCIENCES
Citation Formats
Jacobs, Jon M., Burnum-Johnson, Kristin E., Baker, Erin M., Smith, Richard D., Gritsenko, Marina A., and Orton, Daniel. Biomarkers for liver fibrosis. United States: N. p., 2015.
Web.
Jacobs, Jon M., Burnum-Johnson, Kristin E., Baker, Erin M., Smith, Richard D., Gritsenko, Marina A., & Orton, Daniel. Biomarkers for liver fibrosis. United States.
Jacobs, Jon M., Burnum-Johnson, Kristin E., Baker, Erin M., Smith, Richard D., Gritsenko, Marina A., and Orton, Daniel. Tue .
"Biomarkers for liver fibrosis". United States. https://www.osti.gov/servlets/purl/1214595.
@article{osti_1214595,
title = {Biomarkers for liver fibrosis},
author = {Jacobs, Jon M. and Burnum-Johnson, Kristin E. and Baker, Erin M. and Smith, Richard D. and Gritsenko, Marina A. and Orton, Daniel},
abstractNote = {Methods and systems for diagnosing or prognosing liver fibrosis in a subject are provided. In some examples, such methods and systems can include detecting liver fibrosis-related molecules in a sample obtained from the subject, comparing expression of the molecules in the sample to controls representing expression values expected in a subject who does not have liver fibrosis or who has non-progressing fibrosis, and diagnosing or prognosing liver fibrosis in the subject when differential expression of the molecules between the sample and the controls is detected. Kits for the diagnosis or prognosis of liver fibrosis in a subject are also provided which include reagents for detecting liver fibrosis related molecules.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {Tue Sep 15 00:00:00 EDT 2015},
month = {Tue Sep 15 00:00:00 EDT 2015}
}
Save to My Library
You must Sign In or Create an Account in order to save documents to your library.
Works referenced in this record:
Advancing the High Throughput Identification of Liver Fibrosis Protein Signatures Using Multiplexed Ion Mobility Spectrometry
journal, January 2014
- Baker, Erin Shammel; Burnum-Johnson, Kristin E.; Jacobs, Jon M.
- Molecular & Cellular Proteomics, Vol. 13, Issue 4, p. 1119-1127
HepatoProteomics: Applying proteomic technologies to the study of liver function and disease
journal, January 2006
- Diamond, Deborah L.; Proll, Sean C.; Jacobs, Jon M.
- Hepatology, Vol. 44, Issue 2, p. 299-308
Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver disease
journal, September 2009
- Bell, Lauren N.; Theodorakis, Janice L.; Vuppalanchi, Raj
- Hepatology, Vol. 51, Issue 1, p. 111-120
Usefulness of a novel serum proteome-derived index FI-PRO (fibrosis-protein) in the prediction of fibrosis in chronic hepatitis C
journal, January 2011
- Cheung, Kin Jip; Tilleman, Kelly; Deforce, Dieter
- European Journal of Gastroenterology & Hepatology, Vol. 23, Issue 8, p. 701-710
Diagnostic accuracy of a fibrosis serum panel (FIBRO Spect II) compared with Knodell and Ishak liver biopsy scores in chronic hepatitis C patients
journal, October 2006
- Christensen, C.; Bruden, D.; Livingston, S.
- Journal of Viral Hepatitis, Vol. 13, Issue 10, p. 652-658
Noninvasive Tests for Liver Fibrosis
journal, November 2006
- Mukherjee, Sandeep; Sorrell, Michael
- Seminars in Liver Disease, Vol. 26, Issue 4, p. 337-347
Non-invasive assessment of chronic liver and gastric diseases
journal, May 2007
- Plebani, Mario; Basso, Daniela
- Clinica Chimica Acta, Vol. 381, Issue 1, p. 39-49
Noninvasive measures of liver fibrosis
journal, January 2006
- Rockey, Don C.; Bissell, D. Montgomery
- Hepatology, Vol. 43, Issue S1, p. S113-S120
FibroTest and FibroScan for the Prediction of Hepatitis C-Related Fibrosis: A Systematic Review of Diagnostic Test Accuracy
journal, November 2007
- Shaheen, Abdel Aziz M.; Wan, Alex F.; Myers, Robert P.
- The American Journal of Gastroenterology, Vol. 102, Issue 11, p. 2589-2600